Tag: industry experts
- 
		
		
		Anchore: STIG in Action: Continuous Compliance with MITRE & AnchoreSource URL: https://anchore.com/events/stig-in-action-continuous-compliance-with-mitre-anchore/ Source: Anchore Title: STIG in Action: Continuous Compliance with MITRE & Anchore Feedly Summary: The post STIG in Action: Continuous Compliance with MITRE & Anchore appeared first on Anchore. AI Summary and Description: Yes Summary: The text discusses an upcoming webinar focused on STIG (Security Technical Implementation Guide) compliance, emphasizing recent NIST… 
- 
		
		
		Hacker News: Intel ruined an Israeli startup it bought for $2B–and lost the AI raceSource URL: https://www.calcalistech.com/ctechnews/article/s1tra0sfye Source: Hacker News Title: Intel ruined an Israeli startup it bought for $2B–and lost the AI race Feedly Summary: Comments AI Summary and Description: Yes Summary: The text discusses Intel’s acquisition of Habana Labs and the subsequent decline of both companies in the competitive AI processor market. It highlights failures in strategy,… 
- 
		
		
		Slashdot: Were DeepSeek’s Development Costs Much Higher Than Reported?Source URL: https://slashdot.org/story/25/02/01/0517258/were-deepseeks-development-costs-much-higher-than-reported?utm_source=rss1.0mainlinkanon&utm_medium=feed Source: Slashdot Title: Were DeepSeek’s Development Costs Much Higher Than Reported? Feedly Summary: AI Summary and Description: Yes Summary: The text provides insight into the competitive landscape of AI development, particularly focused on the rapid rise of China’s DeepSeek company. It highlights implications for the U.S. market in terms of pricing strategies… 
- 
		
		
		Hacker News: Schrödinger: The Nvidia biotech partner Jensen Huang told to "think bigger"Source URL: https://hntrbrk.com/schrodinger/ Source: Hacker News Title: Schrödinger: The Nvidia biotech partner Jensen Huang told to "think bigger" Feedly Summary: Comments AI Summary and Description: Yes **Summary**: Schrödinger, a company utilizing quantum mechanics and AI for drug and material discovery, faces challenges in market valuation as it operates in both biotech and software domains. Despite…